873
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Postsurgical neuropathic pain: lidocaine 700 mg medicated plaster or oral treatments in clinical practice

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 725-735 | Received 04 May 2022, Accepted 01 Jun 2022, Published online: 17 Jun 2022

References

  • Treede RD , RiefW , BarkeAet al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). Pain160, 19–27 (2019).
  • Schug SA , Lavand’hommeP , BarkeA , KorwisiB , RiefW , TreedeRD. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain160, 45–52 (2019).
  • Schug SA , BruceJ. Risk stratification for the development of chronic postsurgical pain. Pain Rep.2, e627 (2017).
  • Haroutiunian S , NikolajsenL , FinnerupNB , JensenTS. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain154, 95–102 (2013).
  • Baron R , BinderA , WasnerG. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol.9, 807–819 (2010).
  • Scholz J , FinnerupNB , AttalNet al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain160, 53–59 (2019).
  • Shipton E . Post-surgical neuropathic pain. ANZ J Surg.78, 548–555 (2008).
  • Rief W , KaasaS , JensenRet al. The need to revise pain diagnoses in ICD-11. Pain149, 169–170 (2010).
  • Attal N , CruccuG , BaronRet al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol.17, 1113–e88 (2010).
  • Finnerup NB , AttalN , HaroutounianSet al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol.14, 162–173 (2015).
  • Cheville AL , SloanJA , NorthfeltDWet al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support. Care Cancer17, 451–460 (2009).
  • van Seventer R , BachFW , TothCCet al. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. Eur. J. Neurol.17, 1082–1089 (2010).
  • Bischoff JM , RingstedTK , PetersenM , SommerC , ÜçeylerN , WernerMU. A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial. PLoS One9, e109144 (2014).
  • Sansone P , PassavantiMB , FiorelliAet al. Efficacy of the topical 5% lidocaine medicated plaster in the treatment of chronic post-thoracotomy neuropathic pain. Pain Manage.7, 189–196 (2017).
  • Markman J , ResnickM , GreenbergSet al. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial. J. Neurol.265, 2815–2824 (2018).
  • Pickering G , VouteM , MacianN , GanryH , PereiraB. Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial. Pain160, 1186–1195 (2019).
  • Palladini M , BoeslI , KoenigS , BuchheisterB , AttalN. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial. Curr. Med. Res. Opin.35, 757–766 (2019).
  • Überall MA , BöslI , HollandersE , SabatschusI , EerdekensM. Localized peripheral neuropathic pain – topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice. Pain Manage.12, 521–533 (2022).
  • Schlereth T . Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie). Neurol Res Pract.2, 16 (2020).
  • Überall MA , EerdekensM , BöslI , HollandersE , SabatschusI. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry. Pain Manage.12, 195–209 (2022).
  • German Pain Society . Manual for the German pain questionnaire (in German). https://www.schmerzgesellschaft.de/fileadmin/pdf/DSF_Handbuch_2020.pdf
  • von Korff M , OrmelJ , KeefeFJ , DworkinSF. Grading the severity of chronic pain. Pain50, 133–149 (1992).
  • Schmitt N , GerbershagenHU. The Mainz Staging System (MPSS) for chronic pain. Pain41(Suppl. 5), S484 (1990).
  • Tait RC , ChibnallJT , KrauseS. The pain disability index: psychometric properties. Pain40, 171–182 (1990).
  • Hayes CJ , BhandariNR , KatheN , PayakachatN. Reliability and validity of the medical outcomes study short form-12 version 2 (SF-12v2) in adults with non-cancer pain. Healthcare (Basel)5, 22 (2017).
  • Cappelleri JC , BienenEJ , KoduruV , SadoskyA. Measurement properties of painDETECT by average pain severity. Clinicoecon Outcomes Res.6, 497–504 (2014).
  • Guy W . ECDEU assessment manual for psychopharmacology (DHEW Publication no. ADM 76–338). US Government Printing Office, DC, USA (1976).
  • Navez ML , MonellaC , BöslI , SommerD , DelormeC. 5% lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerability. Pain Ther.4, 1–15 (2015).
  • Buksnys T , ArmstrongN , WorthyGet al. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin. Curr. Med. Res. Opin.36, 101–115 (2020).
  • Katz P , PegoraroV , LiedgensH. Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster. Curr. Med. Res. Opin.33, 1481–1489 (2017).
  • Macedo RDR , SantosJPGD , LobatoES , MendesJP , IkemotoRY , RodriguesLMR. Application of 5% lidocaine adhesive patch in painful surgical scars: clinical trial. Rev. Bras. Ortop. (Sao Paulo)56, 601–614 (2021).
  • Businesswire . FDA grants orphan drug designation to postherpetic neuralgia treatment. https://www.businesswire.com/news/home/20130927005456/en/Zalicus%E2%80%99-Z160-Receives-Orphan-Drug-Designation-for-the-Management-of-Postherpetic-Neuralgia